Skip to main content
Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.830
+0.120 (4.43%)
At close: Mar 9, 2026, 4:00 PM EDT
2.800
-0.030 (-1.06%)
After-hours: Mar 9, 2026, 4:36 PM EDT

Genelux Revenue

In the year 2024, Genelux had annual revenue of $8.00K, down -95.29%.

Revenue (ttm)
$8.00K
Revenue Growth
-95.29%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
125.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.00K-162.00K-95.29%
Dec 31, 2023170.00K-10.90M-98.46%
Dec 31, 202211.07M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Codexis 52.93M
Gossamer Bio 44.05M
Spero Therapeutics 40.55M
Coya Therapeutics 3.99M
Cardiff Oncology 593.00K
Inovio Pharmaceuticals 182.34K
Revenue Rankings

GNLX News

More News